Anji Tumor Immunology Innovation Research Institute (under preparation) is a research institution jointly established by Zhejiang Anji Economic Development Zone and Novatim Immune Therapeutics (Zhejiang) Co., Ltd., focusing on applied research and technology transformation in the field of immuno-oncology. It is expected to be ready for operations by 2025. The research institute aims to promote technological progress by conducting research and application transformation of new technologies and drugs in the field of immuno-oncology.